Cloud Storage Startup Box Shows Confidence as IPO Approaches
Box, a provider of cloud software for file sharing, collaboration and document security, is scheduled to debut on the New York Stock Exchange on January 23, a full 10 months after the Los Altos, California-based More...
Israel’s Check-Cap Planning $15 Million NASDAQ IPO
Israel’s Check-Cap Ltd., a clinical stage medical diagnostics company engaged in the development of gastrointestinal imaging devices for the screening for colorectal cancer, announced that it has filed More...
Australia probes bitcoin crime links as currency craves legitimacy
A top Australian law enforcement agency is investigating bitcoin’s role in organized crime, a senior official said, just as politicians and financial regulators embrace the digital currency More...
Universal flu vaccine co BiondVax mulls NY IPO
– BiondVax is exploring two options – either a conventional offering or listing American Depositary Receipts. – Universal flu vaccine developer BiondVax Pharmaceuticals Ltd. (TASE:BNDX) More...
Perrigo to raise $900 million in NYSE secondary offering
– The company will use the offering to help finance the $4.5 billion acquisition of Omega Pharma. OTC pharmaceutical company Perrigo Company (NYSE:PRGO; TASE:PRGO) has filed a prospectus with the US Securities More...
Israel’s Immune Pharmaceuticals to Issue New Stock
Israel’s Immune Pharmaceuticals Inc., a clinical stage biopharmaceutical company that engages in the development and commercialization of targeted therapeutics for the treatment of inflammatory diseases More...
Morgan Stanley Central in Chinese Stock Dispute
– U.S. banking giant Morgan Stanley helped a Chinese company, Tianhe Chemicals, sell $654 million in stock in a June public offering. But The Associated Press identified significant discrepancies More...
fourth US company files for TASE bond offering
– David Marx’s MDG Real Estate Global wants to use a bond issue to build two Manhattan hotels. – The stream of American-Jewish real estate developers looking for cheap financing in the More...
Pharmaceutical NeuroDerm Prepares for NASDAQ IPO
NeuroDerm Ltd., an Israeli clinical stage pharmaceutical company which develops drugs for central nervous system (CNS) diseases, announced the launch of its initial public offering of 4.5 million ordinary More...
Medical Device Maker Endochoice Eyeing $150 Million IPO
Endochoice, a company which produces all manner of medical devices, is planning a NASDAQ IPO for 2015 which it hopes will bring in $100 to $150 Million. The firm merged with Israel’s endoscopic company More...